These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1567758)

  • 1. Drug targeting in magnetic resonance imaging.
    Weissleder R; Bogdanov A; Papisov M
    Magn Reson Q; 1992 Mar; 8(1):55-63. PubMed ID: 1567758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted contrast agents in MR imaging.
    Gupta H; Weissleder R
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):171-84. PubMed ID: 8673713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chelates in magnetic resonance imaging studies.
    Tripathi L; Kumar P; Singh R
    J Cancer Res Ther; 2009; 5(3):148-53. PubMed ID: 19841554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
    Mulder WJ; Strijkers GJ; van Tilborg GA; Griffioen AW; Nicolay K
    NMR Biomed; 2006 Feb; 19(1):142-64. PubMed ID: 16450332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes for paramagnetic contrast enhancement in n.m.r. imaging.
    Gore JC; Sostman HD; Caride VJ
    J Microencapsul; 1986; 3(4):251-64. PubMed ID: 3334053
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D
    J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lanthanides in magnetic resonance imaging.
    Bottrill M; Kwok L; Long NJ
    Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic considerations in the development of labeled liposomes and micelles for diagnostic imaging.
    Torchilin VP
    Q J Nucl Med; 1997 Jun; 41(2):141-53. PubMed ID: 9203853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
    Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
    Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MultiHance: help or hype?
    Bartolozzi C; Spinazzi A
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S151-9. PubMed ID: 10608411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical application of functionalized magnetic nanoparticles.
    Ito A; Shinkai M; Honda H; Kobayashi T
    J Biosci Bioeng; 2005 Jul; 100(1):1-11. PubMed ID: 16233845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media research 1919. Particles.
    Fischer HW
    Invest Radiol; 1990 Sep; 25 Suppl 1():S2-6. PubMed ID: 2283243
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-time magnetic resonance imaging for interventional neuroradiological procedures.
    Schumacher HC; Dumoulin CL; Feng L; Mangla S; Meyers PM; Hirsch J; Mohr JP; DeLaPaz RL; Pile-Spellman J
    Surg Technol Int; 2003; 11():183-96. PubMed ID: 12931300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast agents for magnetic resonance imaging of the liver.
    Josephson L; Groman E; Weissleder R
    Targeted Diagn Ther; 1991; 4():163-87. PubMed ID: 1797156
    [No Abstract]   [Full Text] [Related]  

  • 17. Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.
    Mohs AM; Lu ZR
    Expert Opin Drug Deliv; 2007 Mar; 4(2):149-64. PubMed ID: 17335412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
    Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
    Low RN
    Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput magnetic resonance imaging in mice for phenotyping and therapeutic evaluation.
    McConville P; Moody JB; Moffat BA
    Curr Opin Chem Biol; 2005 Aug; 9(4):413-20. PubMed ID: 16002325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.